Back

Gene expression and chromatin accessibility comparison in iPSC-derived microglia in African, European, and Amerindian genomes in Alzheimer's patients and controls.

Moura, S.; Nasciben, L. B.; Ramirez, A. M.; Coombs, L.; Rivero, J.; Van Booven, D. J.; DeRosa, B. A.; Hamilton-Nelson, K. L.; Whitehead, P. L.; Adams, L. D.; Starks, T. D.; Mena, P. R.; Illanes-Manrique, M.; Tejada, S.; Byrd, G. S.; Cornejo-Olivas, M. R.; Feliciano-Astacio, B. E.; Nuytemans, K.; Wang, L.; Pericak-Vance, M. A.; Dykxhoorn, D. M.; Rajabli, F.; Griswold, A. J.; Young, J. I.; Vance, J. M.

2024-08-27 genomics
10.1101/2024.08.27.609943 bioRxiv
Show abstract

Alzheimers disease (AD) risk differs between population groups, with African Americans and Hispanics being the most affected groups compared to non-Hispanic Whites. Genetic factors contribute significant risk to AD, but the genetic regulatory architectures (GRA) have primarily been studied in Europeans. Many AD genes are expressed in microglia; thus, we explored the impact of genetic ancestry (Amerindian (AI), African (AF), and European (EU)) on the GRA in iPSC-derived microglia from 13 individuals ([~]4 each with high global ancestry, AD and controls) through ATAC-seq and RNA-seq analyses. We identified several differentially accessible and expressed genes (2 and 10 AD-related, respectively) between ancestry groups. We also found a high correlation between the transcriptomes of iPSC-derived and brain microglia, supporting their use in human studies. This study provides valuable insights into genetically diverse microglia beyond the analysis of AD.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.